Andrew Galligan

Andrew Galligan

Director/Board Member at OOMA, INC.

Net worth: 4 M $ as of 31/05/2026

70 year
Health Technology
Producer Manufacturing
Communications

Profile

Andrew Hugh Galligan is currently a Director at Nevro Medical Ltd. since 2010, an Independent Director at Ooma, Inc. since 2014, and a Fellow at The Institute of Chartered Accountants in Ireland.
Former roles include Director at diaDexus, Inc., Independent Director at Arcellx, Inc. from 2025 to 2026, Independent Director at Diadexus, Inc. from 2011 to 2015, Chief Financial Officer & Vice President at Molecular Devices LLC, Lumisys, Inc., Corcept Therapeutics, Inc., Amira Medical, Inc., IPS Health Care, Inc., and Chief Financial Officer & Vice President-Finance at Reliant Technologies, Inc. from 2007 to 2008, Ooma, Inc. from 2009 to 2010, and Nevro Corp.
from 2010 to 2020.
Chief Financial Officer at Metrika, Inc. from 2003 to 2011.
Education includes undergraduate studies at Trinity College Dublin.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
04/06/2026 250,824 ( 0.91% ) 4 M $ 31/05/2026

Andrew Galligan active positions

CompaniesPositionStart
OOMA, INC. Director/Board Member 01/12/2014
Corporate Officer/Principal -
Director/Board Member 22/07/2010

Former positions of Andrew Galligan

CompaniesPositionEnd
ARCELLX, INC. Director/Board Member 28/04/2026
NEVRO CORP. Director of Finance/CFO 01/07/2020
DIADEXUS, INC. Director/Board Member 07/01/2015
Director of Finance/CFO 26/04/2011
OOMA, INC. Director of Finance/CFO 01/05/2010
See the detail of Andrew Galligan's experience

Training of Andrew Galligan

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

56

1st degree connections

15

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies15

Health Technology

Producer Manufacturing

Health Technology

Health Technology

Health Technology

Communications

Health Technology

Health Technology

Distribution Services

Consumer Services

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Andrew Galligan